表紙
市場調查報告書
商品編碼
121098

血紅素A1c監測的全球市場

Hemoglobin A1C Monitoring

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 268 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球血紅素A1c監測市場相關調查,彙整市場概要與成長趨勢,產品概要,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • HbA1c設備:糖尿病監測和管理上的重要角色
    • 刺激成長因素
    • 主要的顧慮事項
    • 已開發國家主導市場的同時,亞太地區將帶動長期成長
    • 實驗室的HbA1c檢查裝置壟斷市場
    • POC為基礎的HbA1c檢查裝置領導市場
    • 糖尿病的罹患率上升和管理的必要性促使HbA1c監測設備的需求提高
    • 競爭環境
    • 實驗室為基礎的產品/分析設備
    • POC為基礎的產品/分析設備
  • 促進成長要素,趨勢,課題
    • 高齡化導致糖尿病的高風險保証了市場的成長
    • 肥胖度的上升促使市場成長
    • 醫療費高等加速需求
    • 糖尿病診斷HbA1c檢測的批准
    • HbA1c測試是否被推薦用於診斷目的?
    • 技術發展改變糖尿病護理中的診斷
    • 糖尿病診斷的HbA1c檢驗 其他
  • 糖尿病:疾病簡介
    • 原因
    • 種類
    • 主要的併發症
    • 統計資料
    • 治療方法
    • 糖尿病的一般管理方法
  • 產品概要
  • 產品技術創新/引進
  • 近幾年的產業活動
  • 主要企業
    • A.Menarini Diagnostics Ltd.
    • Abbott Laboratories
    • Alere, Inc
    • Arkray株式會社.
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc.
    • Diazyme Laboratories, Inc.
    • EKF Diagnostics Holdings Plc
    • HemoCue® AB
    • OSANG Healthcare Co., Ltd
    • PTS Diagnostics
    • Roche Diagnostics
    • Siemens Healthineers
    • Tosoh Bioscience, Inc.
    • Trinity Biotech plc
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國
目錄
Product Code: MCP-1218

Abstract:

Global Hemoglobin A1C Monitoring Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Hemoglobin A1C Monitoring estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 7.8% over the analysis period 2020-2027. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$734.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunoassays segment is readjusted to a revised 7.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $275.9 Million, While China is Forecast to Grow at 11.8% CAGR

The Hemoglobin A1C Monitoring market in the U.S. is estimated at US$275.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$392.3 Million by the year 2027 trailing a CAGR of 11.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 6.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Boronate Affinity Chromatography Segment to Record 7.2% CAGR

In the global Boronate Affinity Chromatography segment, USA, Canada, Japan, China and Europe will drive the 6.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$122 Million in the year 2020 will reach a projected size of US$191.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$237.4 Million by the year 2027, while Latin America will expand at a 8.5% CAGR through the analysis period.

Select Competitors (Total 28 Featured) -

  • A.Menarini Diagnostics Ltd.
  • Abbott Laboratories
  • Alere Inc.
  • ARKRAY Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • HemoCue® AB
  • OSANG Healthcare Co., Ltd
  • PTS Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Tosoh Bioscience Inc.
  • Trinity Biotech plc

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • What is Glycated Hemoglobin (A1C)?
    • An Introduction to Hemoglobin A1C Monitoring
    • Global Market Prospects & Outlook
    • Ion-Exchange HPLC: The Largest Segment
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Diabetes Prevalence to Propel Growth in HbA1c Monitoring Market
    • Aging Population and High Risk of Diabetes with Advancing Age to Spearhead Market
    • Growing Threat of Undiagnosed Diabetes in Emerging Economies: Potential for Growth
    • HbA1C for Pre-Diabetes Testing
    • Product Innovations & Automated HbA1C Testing Analyzers to Boost Market
    • Approvals for New HbA1C Monitoring Products to Spur Market Opportunities
    • Growing Importance of POC Testing for Diabetes Testing to Present Growth Prospects
    • HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
    • HbA1C Testing for Diabetes Diagnosis Purpose
    • Home HbA1C Testing Presents Opportunities for POC Testing
    • New Regulations Recommend HbA1C Testing
    • Challenges Facing HbA1c Monitoring Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Hemoglobin A1C Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Hemoglobin A1C Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Hemoglobin A1C Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Point-of-Care (POC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Point-of-Care (POC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Point-of-Care (POC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Hemoglobin A1C Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Hemoglobin A1C Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Hemoglobin A1C Monitoring by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 82: Spain Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Spain Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Spain 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 85: Spain Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 88: Russia Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Russia Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Russia 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 91: Russia Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of Europe Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of Europe 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 100: Asia-Pacific Current & Future Analysis for Hemoglobin A1C Monitoring by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 101: Asia-Pacific Historic Review for Hemoglobin A1C Monitoring by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Asia-Pacific 15-Year Perspective for Hemoglobin A1C Monitoring by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 109: Australia Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Australia Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Australia 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 112: Australia Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 115: India Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: India Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: India 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 118: India Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 121: South Korea Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: South Korea Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: South Korea 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 124: South Korea Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Asia-Pacific Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 133: Latin America Current & Future Analysis for Hemoglobin A1C Monitoring by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America Historic Review for Hemoglobin A1C Monitoring by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Latin America 15-Year Perspective for Hemoglobin A1C Monitoring by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 142: Argentina Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Argentina Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Argentina 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 145: Argentina Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 148: Brazil Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Brazil Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Brazil 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 151: Brazil Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 154: Mexico Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Mexico Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Mexico 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 157: Mexico Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Latin America Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Latin America 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 163: Rest of Latin America Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 166: Middle East Current & Future Analysis for Hemoglobin A1C Monitoring by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 167: Middle East Historic Review for Hemoglobin A1C Monitoring by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Middle East 15-Year Perspective for Hemoglobin A1C Monitoring by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 175: Iran Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Iran Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Iran 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 178: Iran Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 181: Israel Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Israel Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Israel 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 184: Israel Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 187: Saudi Arabia Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Saudi Arabia Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Saudi Arabia 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 190: Saudi Arabia Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 193: UAE Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: UAE Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: UAE 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 196: UAE Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 199: Rest of Middle East Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Rest of Middle East Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Rest of Middle East 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 202: Rest of Middle East Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 205: Africa Current & Future Analysis for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Africa Historic Review for Hemoglobin A1C Monitoring by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Africa 15-Year Perspective for Hemoglobin A1C Monitoring by Technology - Percentage Breakdown of Value Sales for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 208: Africa Current & Future Analysis for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Hemoglobin A1C Monitoring by End-Use - Laboratory Testing and Point-of-Care (POC) Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Hemoglobin A1C Monitoring by End-Use - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care (POC) Testing for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 28